Literature DB >> 10854058

Clusterin protects granulosa cells from apoptotic cell death during follicular atresia.

I Zwain1, P Amato.   

Abstract

Clusterin expression is associated with programmed cell death (apoptosis) in many cell types but its exact role has not yet been defined. This study was carried out to determine the cellular localization of clusterin in the ovary and its functional role in the apoptotic cell death of ovarian follicles. A homogenous population of healthy and atretic follicles was obtained by treating immature rats with pregnant mare serum gonadotropin (PMSG). Apoptotic cell death was evaluated by TUNEL. Clusterin expression in the healthy and atretic follicles was examined by immunohistochemical and Western blot analyses, and gene expression was examined by Northern blot analysis. Clusterin protein and its mRNA are only expressed in granulosa cells of atretic follicles obtained from PMSG-treated rats on day 5 of the treatment. Healthy follicles from PMSG-treated rats on day 2 of the treatment do not express clusterin. Theca and stroma cells of both healthy and atretic follicles showed no signs of apoptosis and did not express clusterin. Withdrawal of trophic support from granulosa cells in cultures to induce apoptosis resulted in a dramatic increase in the levels of clusterin and its mRNA compared to cells cultured in serum-supplemented medium. In an attempt to establish the functional role of clusterin in the apoptotic cell death of ovarian follicles, the biosynthesis of clusterin in granulosa cells of healthy follicles was blocked by treatment of cells with antisense oligonucleotide to its cDNA. Treatment of granulosa cells with the antisense oligonucleotide resulted in an increase in the apoptotic cell death compared to the control. These findings indicate that depletion of clusterin can lead to the programmed cell death in ovary, suggesting a functional role for this protein in follicular atresia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854058     DOI: 10.1006/excr.2000.4885

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Increase in clusterin-containing follicles in the adenohypophysis of drug abusers.

Authors:  Takaki Ishikawa; Bao-Li Zhu; Satoru Miyaishi; Hideo Ishizu; Hitoshi Maeda
Journal:  Int J Legal Med       Date:  2006-11-18       Impact factor: 2.686

2.  Regulation of clusterin expression in mammary epithelial cells.

Authors:  Yoko Itahana; Marie Piens; Tomoki Sumida; Sylvia Fong; John Muschler; Pierre-Yves Desprez
Journal:  Exp Cell Res       Date:  2006-12-24       Impact factor: 3.905

3.  Steroid hormones content and proteomic analysis of canine follicular fluid during the preovulatory period.

Authors:  Somayyeh Fahiminiya; Karine Reynaud; Valérie Labas; Séverine Batard; Sylvie Chastant-Maillard; Nadine Gérard
Journal:  Reprod Biol Endocrinol       Date:  2010-11-01       Impact factor: 5.211

Review 4.  Clusterin: a key player in cancer chemoresistance and its inhibition.

Authors:  Tomas Koltai
Journal:  Onco Targets Ther       Date:  2014-03-20       Impact factor: 4.147

Review 5.  Exploring the translational potential of clusterin as a biomarker of early osteoarthritis.

Authors:  Ursule Kalvaityte; Csaba Matta; Eiva Bernotiene; Peter Natesan Pushparaj; Ata M Kiapour; Ali Mobasheri
Journal:  J Orthop Translat       Date:  2021-12-10       Impact factor: 5.191

6.  The highly prolific phenotype of Lacaune sheep is associated with an ectopic expression of the B4GALNT2 gene within the ovary.

Authors:  Laurence Drouilhet; Camille Mansanet; Julien Sarry; Kamila Tabet; Philippe Bardou; Florent Woloszyn; Jérome Lluch; Grégoire Harichaux; Catherine Viguié; Danielle Monniaux; Loys Bodin; Philippe Mulsant; Stéphane Fabre
Journal:  PLoS Genet       Date:  2013-09-26       Impact factor: 5.917

7.  Expression profiles of Fsh-regulated ovarian genes during oogenesis in coho salmon.

Authors:  José M Guzmán; J Adam Luckenbach; Yoji Yamamoto; Penny Swanson
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.